CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice

Xun Sun, Hisakata Yamada, Kensuke Shibata, Hiromi Muta, Kenzaburo Tani, Eckhard R. Podack, Yasunobu Yoshikai

    Research output: Contribution to journalArticle

    35 Citations (Scopus)

    Abstract

    A CD30 ligand (CD30L; CD153) and its receptor, CD30, is a membrane-associated glycoprotein belonging to the TNF superfamily and TNFR superfamily. These were expressed preferentially by activated CD4+T cells. In this paper, we show that CD44lowCD62hi CD4 + T cells from CD30L-/- or CD30-/- mice exhibited impaired differentiation into Th17 cells but an increased ability to produce IL-2 after in vitro culture under Th17-polarizing conditions. Neutralization with IL-2 by anti-IL-2 mAb partly restored the ability of Th17 differentiation in CD30L-/- or CD30-/- T cells. Stimulation via CD30L by immobilized anti-CD30L mAb suppressed IL-2 production by CD30-/-CD4+ T cells, indicating that the reverse signal to CD30L is responsible for down-regulation of IL-2 production. In vivo Th17 differentiation of CD30L-/-CD4+CD45RBhigh T cells was also impaired after transfer into SCID mice, whereas CD30L +/+CD4+CD45RBhigh T cells normally differentiated into Th17 cells in CD30L-/-SCID mice. The results of these studies demonstrate that CD30L/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation, at least partly via downregulation of IL-2 production.

    Original languageEnglish
    Pages (from-to)2222-2230
    Number of pages9
    JournalJournal of Immunology
    Volume185
    Issue number4
    DOIs
    Publication statusPublished - Aug 15 2010

    Fingerprint

    CD30 Ligand
    Interleukin-2
    T-Lymphocytes
    Th17 Cells
    SCID Mice
    Down-Regulation
    Membrane Glycoproteins
    Cell Communication
    Cell Differentiation

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology

    Cite this

    Sun, X., Yamada, H., Shibata, K., Muta, H., Tani, K., Podack, E. R., & Yoshikai, Y. (2010). CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. Journal of Immunology, 185(4), 2222-2230. https://doi.org/10.4049/jimmunol.1000024

    CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. / Sun, Xun; Yamada, Hisakata; Shibata, Kensuke; Muta, Hiromi; Tani, Kenzaburo; Podack, Eckhard R.; Yoshikai, Yasunobu.

    In: Journal of Immunology, Vol. 185, No. 4, 15.08.2010, p. 2222-2230.

    Research output: Contribution to journalArticle

    Sun, X, Yamada, H, Shibata, K, Muta, H, Tani, K, Podack, ER & Yoshikai, Y 2010, 'CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice', Journal of Immunology, vol. 185, no. 4, pp. 2222-2230. https://doi.org/10.4049/jimmunol.1000024
    Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER et al. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. Journal of Immunology. 2010 Aug 15;185(4):2222-2230. https://doi.org/10.4049/jimmunol.1000024
    Sun, Xun ; Yamada, Hisakata ; Shibata, Kensuke ; Muta, Hiromi ; Tani, Kenzaburo ; Podack, Eckhard R. ; Yoshikai, Yasunobu. / CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. In: Journal of Immunology. 2010 ; Vol. 185, No. 4. pp. 2222-2230.
    @article{bd0a94fab2b4464984371bdb7916167f,
    title = "CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice",
    abstract = "A CD30 ligand (CD30L; CD153) and its receptor, CD30, is a membrane-associated glycoprotein belonging to the TNF superfamily and TNFR superfamily. These were expressed preferentially by activated CD4+T cells. In this paper, we show that CD44lowCD62hi CD4 + T cells from CD30L-/- or CD30-/- mice exhibited impaired differentiation into Th17 cells but an increased ability to produce IL-2 after in vitro culture under Th17-polarizing conditions. Neutralization with IL-2 by anti-IL-2 mAb partly restored the ability of Th17 differentiation in CD30L-/- or CD30-/- T cells. Stimulation via CD30L by immobilized anti-CD30L mAb suppressed IL-2 production by CD30-/-CD4+ T cells, indicating that the reverse signal to CD30L is responsible for down-regulation of IL-2 production. In vivo Th17 differentiation of CD30L-/-CD4+CD45RBhigh T cells was also impaired after transfer into SCID mice, whereas CD30L +/+CD4+CD45RBhigh T cells normally differentiated into Th17 cells in CD30L-/-SCID mice. The results of these studies demonstrate that CD30L/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation, at least partly via downregulation of IL-2 production.",
    author = "Xun Sun and Hisakata Yamada and Kensuke Shibata and Hiromi Muta and Kenzaburo Tani and Podack, {Eckhard R.} and Yasunobu Yoshikai",
    year = "2010",
    month = "8",
    day = "15",
    doi = "10.4049/jimmunol.1000024",
    language = "English",
    volume = "185",
    pages = "2222--2230",
    journal = "Journal of Immunology",
    issn = "0022-1767",
    publisher = "American Association of Immunologists",
    number = "4",

    }

    TY - JOUR

    T1 - CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice

    AU - Sun, Xun

    AU - Yamada, Hisakata

    AU - Shibata, Kensuke

    AU - Muta, Hiromi

    AU - Tani, Kenzaburo

    AU - Podack, Eckhard R.

    AU - Yoshikai, Yasunobu

    PY - 2010/8/15

    Y1 - 2010/8/15

    N2 - A CD30 ligand (CD30L; CD153) and its receptor, CD30, is a membrane-associated glycoprotein belonging to the TNF superfamily and TNFR superfamily. These were expressed preferentially by activated CD4+T cells. In this paper, we show that CD44lowCD62hi CD4 + T cells from CD30L-/- or CD30-/- mice exhibited impaired differentiation into Th17 cells but an increased ability to produce IL-2 after in vitro culture under Th17-polarizing conditions. Neutralization with IL-2 by anti-IL-2 mAb partly restored the ability of Th17 differentiation in CD30L-/- or CD30-/- T cells. Stimulation via CD30L by immobilized anti-CD30L mAb suppressed IL-2 production by CD30-/-CD4+ T cells, indicating that the reverse signal to CD30L is responsible for down-regulation of IL-2 production. In vivo Th17 differentiation of CD30L-/-CD4+CD45RBhigh T cells was also impaired after transfer into SCID mice, whereas CD30L +/+CD4+CD45RBhigh T cells normally differentiated into Th17 cells in CD30L-/-SCID mice. The results of these studies demonstrate that CD30L/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation, at least partly via downregulation of IL-2 production.

    AB - A CD30 ligand (CD30L; CD153) and its receptor, CD30, is a membrane-associated glycoprotein belonging to the TNF superfamily and TNFR superfamily. These were expressed preferentially by activated CD4+T cells. In this paper, we show that CD44lowCD62hi CD4 + T cells from CD30L-/- or CD30-/- mice exhibited impaired differentiation into Th17 cells but an increased ability to produce IL-2 after in vitro culture under Th17-polarizing conditions. Neutralization with IL-2 by anti-IL-2 mAb partly restored the ability of Th17 differentiation in CD30L-/- or CD30-/- T cells. Stimulation via CD30L by immobilized anti-CD30L mAb suppressed IL-2 production by CD30-/-CD4+ T cells, indicating that the reverse signal to CD30L is responsible for down-regulation of IL-2 production. In vivo Th17 differentiation of CD30L-/-CD4+CD45RBhigh T cells was also impaired after transfer into SCID mice, whereas CD30L +/+CD4+CD45RBhigh T cells normally differentiated into Th17 cells in CD30L-/-SCID mice. The results of these studies demonstrate that CD30L/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation, at least partly via downregulation of IL-2 production.

    UR - http://www.scopus.com/inward/record.url?scp=77956897477&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77956897477&partnerID=8YFLogxK

    U2 - 10.4049/jimmunol.1000024

    DO - 10.4049/jimmunol.1000024

    M3 - Article

    C2 - 20639486

    AN - SCOPUS:77956897477

    VL - 185

    SP - 2222

    EP - 2230

    JO - Journal of Immunology

    JF - Journal of Immunology

    SN - 0022-1767

    IS - 4

    ER -